Autopsy report · NCT04142658

PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban

“Safety”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months before it started.
• Ran for about 2 years 7 months before it stopped.
• 863 participants enrolled.
• Results were posted on the registry 1 year 3 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Artivion Inc.

Sponsor type

Industry

Conditions

Aortic Valve Disease; Aortic Valve Stenosis; Aortic Valve Failure

Interventions

Apixaban 5 MG; Apixaban 2.5 MG; Warfarin; On-X Aortic Mechanical Valve

Participants

863

Sites

62

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.